KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Invested Capital (2016 - 2025)

Pacira BioSciences (PCRX) has 16 years of Invested Capital data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Invested Capital fell 21.88% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 21.88%, while the annual FY2025 figure was $1.1 billion, 21.88% down from the prior year.
  • Invested Capital reached $1.1 billion in Q4 2025 per PCRX's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $1.5 billion in Q4 2022 and bottomed at $743.3 million in Q1 2022.
  • Average Invested Capital over 5 years is $1.0 billion, with a median of $876.8 million recorded in 2021.
  • Peak YoY movement for Invested Capital: skyrocketed 116.63% in 2021, then decreased 21.88% in 2025.
  • A 5-year view of Invested Capital shows it stood at $931.7 million in 2021, then skyrocketed by 57.19% to $1.5 billion in 2022, then fell by 4.91% to $1.4 billion in 2023, then decreased by 2.08% to $1.4 billion in 2024, then fell by 21.88% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.3 billion in Q2 2025.